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Epidural analgesia is often considered optimal postoperative
analgesia after major lower abdominal or lower extremity
surgery [1–3], and patient-controlled epidural analgesia
(PCEA) has gained popularity [4–6]. Epidural infusions
usually comprise a local anesthetic, an opioid, or a
combination of the two, to improve analgesic efficacy and
reduce unwanted side effects [7–9].
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Epidural analgesia is often considered optimal postoperative analgesia for certain surgical procedures.
Ropivacaine is a new local anesthetic that is less toxic than its homologue, bupivacaine. Epidural infusions
usually comprise a local anesthetic, an opioid, or a combination of the two to improve analgesic efficacy
and reduce unwanted side effects. All 210 patients undergoing lower abdominal or lower extremity surgery
received epidural analgesia infusions at 7 mL/hour, 105 with 0.1% ropivacaine and 105 with 0.1%
ropivacaine plus 1 µg/mL fentanyl. Pain score and side effects (hypotension, nausea, vomiting, pruritus,
paresthesia, urinary retention and motor block) were measured at 0, 0.5, 1, 3, 6, 12, and 24 hours. There
was no statistical difference in patient profile between the groups. Pain relief scores were similar in the
two groups in the first hour after the drugs were given. However, pain relief was significantly better in
the ropivacaine/fentanyl group after the first hour and this difference lasted for the remaining time. There
was no significant difference in adverse events between the two groups during 24 hours of assessment.
In conclusion, the quality of analgesia was significantly improved by the addition of fentanyl 1 µg/mL
to ropivacaine.
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Ropivacaine is a new local anesthetic for epidural
analgesia. Epidural ropivacaine appears to be superior to its
homologue bupivacaine because of decreased motor block
potency [10], making it less toxic. The optimal concentration
of ropivacaine when used alone for epidural analgesia is
2 mg/mL [2,11,12], but this often gives inadequate analgesia
or excessive motor block [13,14]. If a combination of both
local anesthetic and opioid is used with the addition of
fentanyl [15], the optimal concentration of fentanyl seems to
lie in the range of 1–5 µg/mL [16]. This combination can
improve analgesia and allow the use of a 0.1% solution of
epidural ropivacaine with a decreased risk of motor block
[17]. Although the combination of epidural opioid with
local anesthetics is known to provide superior analgesia in
the postoperative period, epidural ropivacaine has not been
evaluated in combination with low-dose opioid for
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postoperative analgesia. Therefore, we designed this
randomized, double-blind study to evaluate the effect of
the addition of opioid to ropivacaine for postoperative
analgesia.
MATERIALS AND METHODS
The study protocol was approved by the education and
research committee in our hospital, and written informed
consent was obtained from each patient. A total of 210
healthy patients were to receive epidural anesthesia for
lower abdominal surgery or lower extremity surgery.
Patients were randomly allocated into two groups. Exclusion
criteria were as follows: American Society of Anesthe-
siologists physical status more than III, age less than 18 or
more than 85 years, weight less than 50 kg or more than 110 kg,
allergy to local anesthetics or opioid, or inability to
understand the use of PCEA. Patients who were not
considered suitable candidates for epidural anesthesia were
also excluded. The pharmacist packaged and labeled drugs
so that the study medications were indistinguishable and
could only be identified by breaking the code.
All patients received standard epidural anesthetic. An
epidural catheter was placed 4 cm into the epidural space at
the L2–L3, L3–L4, or L4–L5 interspace depending on the site of
the proposed surgical incision. After insertion and negative
aspiration of blood or cerebrospinal fluid, an epidural test
dose (3 mL of 2% lidocaine with 1:200,000 epinephrine) was
injected through the catheter. After 5 minutes, if no
intravascular or intrathecal injection was evident, a dose of
2–10 mL of 2% lidocaine with epinephrine was given
incrementally over 5 minutes. Administration was stopped
when the bilateral sensory block of definite dermatome was
reached.
Before the surgical procedure, patients were randomized
in a double-blind manner to receive ropivacaine without
(Group R, 0.1% ropivacaine) or with fentanyl (Group RF,
0.1% ropivacaine plus 1 µg/mL fentanyl) for postoperative
epidural analgesia. Time zero for postoperative infusion
was the time of patient arrival in the post-anesthesia care
unit. The epidural infusion was delivered at a loading dose
of 8 mL followed by a continual dose of 7 mL/hour, with a
3 mL bolus on successful demand at a 40 minute lockout
period.
Pain and sensory and motor block assessments were
recorded immediately before initiation of epidural analgesia
(time zero) and then at 30 minutes and 1, 3, 6, 12, and 24
hours after administration of the study solution. Pain was
assessed using a visual analog scale (VAS; 0 = no pain to
10 = worst pain imaginable), sensory level was assessed
using pinprick, and motor block was assessed using a
modified Bromage scale (0 = no motor block, 1 = unable to
raise extended leg but able to move knee and foot, 2 =
unable to raise extended leg or knee but able to move foot,
3 = complete motor block of lower limb).
Patients with inadequate analgesia (VAS = 5) received a
4 mL bolus of study solution and a 2 mL/hour increment in the
rate of continual infusion and were reassessed 15 minutes
later. Hypotension, defined as a decrease in systolic blood
pressure of more than 20% from baseline, was initially treated
with intravenous (IV) fluids and IV boluses of 8 mg ephedrine
as required. At each assessment time, patients were assessed
for the presence of nausea, vomiting, pruritus, urinary retention,
and paresthesia.
RESULTS
Demographic characteristics were similar in the two groups
(Table 1). There was no statistical difference in pain relief
score in the two groups within the first hour of epidural
analgesia. However, pain relief was much improved from 1
hour (Figure 1). With regard to the VAS, pain relief in Group
R seemed to peak at about 3 during 24 hours, while it
appeared to peak at around 4.5 in Group RF. Bolus demand
was most frequent in Group R (74%, 78 patients; Figure 2).
This showed that the 0.1% ropivacaine used in Group R was
inadequate. There was no significant difference in the
incidence of side effects between the two groups (p > 0.05;
Table 2).
DISCUSSION
A number of studies report superior pain control with
epidural infusions of local anesthetics with or without
opioids, compared to systemic opioids, after lower
abdominal surgery [18–22]. The use of PCEA has become
more popular and is safe and effective in hospital wards [4].
Some studies have found several benefits of PCEA over
conventional epidural continuous infusion or bolus
techniques, including better analgesia and superior patient
satisfaction [4].
Ropivacaine is a relatively new local anesthetic that may
have decreased potency for motor block in epidural use
when compared on a mg/mg basis to bupivacaine [10,23].
Use of a  0.2% ropivacaine solution, with or without fentanyl,
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Table 1. Demographic data
Group R Group RF
(n = 105)  (n = 105)
Age (yr) 33 ± 2.83 31 ± 3.26
Sex (M/F) 57/48 60/45
ASA (I/II/III) 51/34/20 44/40/21
Height (cm) 162 ± 5.66 163.5 ± 6.94
Weight (kg) 67 ± 3.83 65.5 ± 6.87
Values are expressed as mean ±  standard deviation or number.
Group R = 0.1% ropivacaine; Group RF = 0.1% ropivacaine +
1 µg/mL fentanyl; M = male; F = female; ASA = American Society
of Anesthesiologists physical status grade.
provided effective pain relief in most major abdominal
surgery with a very low degree of motor blockade [24].
Some previous studies on dose and concentration have
determined that concentrations of ropivacaine of 0.05–0.1%
are optimal for epidural analgesia when combined with
fentanyl [17,25]. Low concentrations of local anesthetic are
used for epidural analgesia in lower abdominal and lower
extremity surgery to minimize motor block and lessen side
effects.
Both basic research [26–30] and clinical studies
evaluating postoperative pain [31] have demonstrated
synergistic effects between local anesthetics and opioids. In
spite of the widely held impression that the combination of
epidural local anesthetics and opioids provides superior
analgesia with less untoward effects than epidural local
anesthetics alone, the mechanism of action of epidurally
administered opioids remains unclear. Spinal opioids exert
their analgesic effects by reducing neurotransmitter release
at the presynaptic level and by hyperpolarizing the
membrane of dorsal horn neurons at the postsynaptic level
[32]. Epidural opioids have the advantage of producing
analgesia without motor or sympathetic blockade. The
mechanism of postoperative fentanyl analgesia after
epidural administration is primarily systemic. However,
there are also studies to suggest that a spinal effect may
occur after epidural administration of fentanyl [33–36].
Therefore, in clinical practice, the objectives of co-
administration of epidural opioids with subanesthetic
concentrations of local anesthetics are important for three
reasons: a reduction in the dose of both drugs (Figure 2) [17,
37], maintenance or enhancement of the degree of pain
relief, and a reduction in the incidence of adverse effects
produced by both opioids and/or local anesthetics [37].
Side effects limit the effectiveness of many analgesic
therapies, and motor block is a major concern with local
Figure 2. Percentage additional dose (bolus demand) required by patients
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Table 2. Side effects with ropivacaine (Group R) and
ropivacaine/fentanyl (Group RF)
Group R Group RF
n (%) n (%)
Hypotension 0 (0) 2 (1.9)
Nausea 0 (0) 3 (2.9)
Vomiting 1 (1.0) 3 (2.9)
Pruritus 0 (0) 1 (1.0)
Paresthesia 2 (1.9) 3 (2.9)
Urinary retention 0 (0) 1 (1.0)
Figure 1. Visual analog scale (VAS) score for pain relief with epidural
blockade with 0.1% ropivacaine (Group R) and 0.1% ropivacaine +
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anesthetics. The incidence of motor block was very low in
both groups, as might be expected from using a small dose
of ropivacaine at a lumbar spinal level. The combination of
ropivacaine and fentanyl provided more profound
sympathetic blockade due to the synergistic spinal effects
mentioned above, which more readily manifested
hypotension in hypovolemic patients. Opioid-related side
effects were predictably more common in Group RF patients,
with pruritus and nausea being most frequently reported.
In conclusion, an epidural infusion of ropivacaine 0.1%
with or without fentanyl provided effective pain relief in
most patients, with a low degree of motor block. The quality
of analgesia was, however, significantly improved by the
addition of fentanyl 1 µg/mL. Side effects of hypotension,
nausea, and pruritus were found with fentanyl, but were
not statistically significant.
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